LBF20000PG01: Difference between revisions
No edit summary |
No edit summary |
||
| (7 intermediate revisions by the same user not shown) | |||
| Line 6: | Line 6: | ||
|LipidBank=XPR1707 | |LipidBank=XPR1707 | ||
|LipidMaps=LMFA03010144 | |LipidMaps=LMFA03010144 | ||
|SysName=9- | |SysName=9-Oxo- (11alpha,15S) -dihydroxy-prostan-1-oic acid | ||
|Common Name=&&13,14-dihydro Prostaglandin E_1 | |Common Name=&&13,14-dihydro Prostaglandin E_1&& | ||
|Source= | |Source= | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
Latest revision as of 17:57, 26 May 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1707 |
| LipidMaps | LMFA03010144 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20000PG01 |
| 13,14-dihydro Prostaglandin E1 | |
|---|---|
| |
| Structural Information | |
| 9-Oxo- (11α,15S) -dihydroxy-prostan-1-oic acid | |
| |
| Formula | C20H36O5 |
| Exact Mass | 356.256274262 |
| Average Mass | 356.49684 |
| SMILES | C(CC[C@@H](O)CC[C@H]([C@H]1CCCCCCC(O)=O)[C@@H](CC1=O)O)CC |
| Physicochemical Information | |
| 13,14-dihydro PGE1 is an inhibitor of ADP-induced platelet aggregation in human PRP. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
